One site for Breaking News, Politics, Sports, Entertainment & more!

Newz Chooze
Back

The Food and Drug Administration said Monday it has taken action against 17 companies that are "illegally selling" more than 58 products that claim to prevent, treat or cure Alzheimer's disease or other diseases and health conditions. The actions are in the form of warning letters to 12 companies and online advisory letters to 5 companies, which are selling products, many as dietary supplements, that are unapproved new drugs. "These products, which are often sold on websites and social media platforms, have not been reviewed by the FDA and are not proven safe and effective to treat the diseases and health conditions they claim to treat," the FDA stated. "These products may be ineffective, unsafe and could prevent a person from seeking an appropriate diagnosis and treatment." The FDA's warnings come as some companies have claimed that products infused with CBD, or cannabinoids, can help treat diseases ranging from Alzheimer's, Parkinson's, eating disorders and epilepsy. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.